4.47
price down icon2.19%   -0.10
after-market After Hours: 4.41 -0.06 -1.34%
loading
Abcellera Biologics Inc stock is traded at $4.47, with a volume of 4.70M. It is down -2.19% in the last 24 hours and up +30.32% over the past month. AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
See More
Previous Close:
$4.57
Open:
$4.54
24h Volume:
4.70M
Relative Volume:
0.79
Market Cap:
$1.33B
Revenue:
$38.03M
Net Income/Loss:
$-146.40M
P/E Ratio:
-8.5962
EPS:
-0.52
Net Cash Flow:
$-121.38M
1W Performance:
-10.96%
1M Performance:
+30.32%
6M Performance:
+41.01%
1Y Performance:
+37.12%
1-Day Range:
Value
$4.42
$4.6398
1-Week Range:
Value
$4.42
$5.1868
52-Week Range:
Value
$1.8906
$5.82

Abcellera Biologics Inc Stock (ABCL) Company Profile

Name
Name
Abcellera Biologics Inc
Name
Phone
(604) 559-9005
Name
Address
150 W 4TH AVENUE, VANCOUVER
Name
Employee
596
Name
Twitter
Name
Next Earnings Date
2024-11-18
Name
Latest SEC Filings
Name
ABCL's Discussions on Twitter

Compare ABCL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ABCL
Abcellera Biologics Inc
4.47 1.36B 38.03M -146.40M -121.38M -0.52
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.87 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.46 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
392.24 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
670.33 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
301.13 32.46B 3.81B -644.79M -669.77M -6.24

Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-07-25 Resumed Leerink Partners Outperform
Aug-20-24 Downgrade The Benchmark Company Buy → Hold
Feb-22-24 Upgrade The Benchmark Company Hold → Buy
Dec-05-23 Initiated KeyBanc Capital Markets Overweight
Nov-06-23 Downgrade The Benchmark Company Buy → Hold
Oct-13-23 Resumed Piper Sandler Overweight
Feb-28-23 Initiated Cowen Outperform
Dec-15-22 Initiated Goldman Buy
Nov-16-22 Initiated Truist Buy
Dec-21-21 Initiated The Benchmark Company Buy
Nov-19-21 Initiated Piper Sandler Overweight
Jan-05-21 Initiated BMO Capital Markets Outperform
Jan-05-21 Initiated Berenberg Buy
Jan-05-21 Initiated Credit Suisse Outperform
Jan-05-21 Initiated SVB Leerink Outperform
Jan-05-21 Initiated Stifel Buy
View All

Abcellera Biologics Inc Stock (ABCL) Latest News

pulisher
Jul 31, 2025

Piper Sandler Reiterates a Buy Rating on AbCellera Biologics (ABCL) - Insider Monkey

Jul 31, 2025
pulisher
Jul 31, 2025

What is the risk reward ratio of investing in AbCellera Biologics Inc. stockRetirement Planning Growth Plan With Proven Results - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey

Jul 31, 2025
pulisher
Jul 31, 2025

AbCellera Biologics Inc. (ABCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance

Jul 31, 2025
pulisher
Jul 31, 2025

Is it the right time to buy AbCellera Biologics Inc. stockAdvanced Screener Report With High Returns - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What is AbCellera Biologics Inc. company’s growth strategyExpert Picks Guidance For 2025 - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Why is AbCellera Biologics Inc. stock attracting strong analyst attentionBreakout Stocks Recommendation With Proven Results - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 30, 2025

Global Antibody Discovery Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight - GlobeNewswire Inc.

Jul 30, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 06:49:21 - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

What are AbCellera Biologics Inc. company’s key revenue driversBreakout Stocks Updates With Proven Results - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why AbCellera Biologics Inc. stock attracts strong analyst attentionWeekly Return Pick Forecast Reports Show Trend - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Why AbCellera Biologics Inc. stock is on top investor watchlistsEntry Plan for Oversold Reversal Stocks Released - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

How strong is AbCellera Biologics Inc. company’s balance sheetChart Pattern Trend Scanner With Low Risk - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Does AbCellera Biologics Inc. stock perform well during market downturnsMaximize gains with proven stock analysis - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why AbCellera Biologics Inc. stock is on top investor watchlists Technical Reversal Setup with Risk Limits - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of AbCellera Biologics Inc. stockStay informed with daily expert analysis - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Should I hold or sell AbCellera Biologics Inc. stock in 2025Free Market Dynamics Reports - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How volatile is AbCellera Biologics Inc. stock compared to the marketGet daily updates on promising stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for AbCellera Biologics Inc. in the next 12 monthsLow Risk Alerts With Proven Results - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is AbCellera Biologics Inc. stock overvalued or undervaluedGet exclusive market analysis for investors - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is AbCellera Biologics Inc. stock expected to show significant growthSuperior return velocity - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does AbCellera Biologics Inc. compare to its industry peersHarness the power of proven investment plans - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does AbCellera Biologics Inc. generate profit in a changing economyStay ahead with daily expert stock picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

AbCellera Biologics Inc. (ABCL): A Bull Case Theory - MSN

Jul 26, 2025
pulisher
Jul 26, 2025

AbCellera’s AI Antibody Platform Excites Investors, Despite Big Risks - Finimize

Jul 26, 2025
pulisher
Jul 25, 2025

Is AbCellera Biologics Inc. a good long term investmentConsistent double returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is AbCellera Biologics Inc. stock a good hedge against inflationSkyrocketing profit margins - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

AbCellera Biologics Inc. Stock Analysis and ForecastExceptional risk-adjusted gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about AbCellera Biologics Inc. stockRapid wealth creation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What drives AbCellera Biologics Inc. stock priceExponential return rates - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

AbCellera: Just Another Biotech Stock (NASDAQ:ABCL) - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

Leerink Partners Affirms Outperform Rating on AbCellera Biologics (ABCL) Following Pivot - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Strength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength? - MSN

Jul 23, 2025

Abcellera Biologics Inc Stock (ABCL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$74.89
price down icon 3.43%
$36.80
price down icon 0.86%
$107.28
price up icon 2.00%
$26.37
price down icon 1.09%
$107.50
price down icon 2.32%
biotechnology ONC
$301.13
price up icon 0.40%
Cap:     |  Volume (24h):